Collection: Sleep
IgniREM Sleep™ and every protocol built around it. In a 21-day randomized, placebo-controlled trial of 60 adults aged 40–76, participants taking IgniREM Sleep increased their share of REM sleep by an average of 24.6% (p<0.001), measured with a consumer sleep tracker. Twenty-six of thirty participants improved; four saw no change.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.